Resolution Minerals secures FAST-41 status in Idaho
Resolution Minerals (ASX:RML) has secured FAST-41 status for its Antimony Ridge project in Idaho.
Brie Carter
TV Presenter & Finance EditorTV presenter and finance editor at Grafa, with a Master’s in Commerce from UWA and diverse industry experience in finance, insurance, and media.
Contact
Contact editorial teamArticles by Brie Carter
Insights
The bull market in bloodshed
For years, the global defence industry existed in a sort of polite exile.
In the era of ESG mandates and the "peace dividend," shares in weapons manufacturers were often treated as the "tobacco stocks" of the new millennium — profitable, perhaps, but unseemly.
Hot Chili hits high-grade copper extension in Chile
Hot Chili (ASX:HCH) reported a breakthrough at its Costa Fuego Copper-Gold Project in coastal Chile.
Multistack International to sell assets, pivot business strategy
Multistack International (ASX:MSI) to exit core business via asset sale to Willing Y, pivoting to seek new opportunities.
Health
Lumos secures Micro-Pak manufacturing deal and order
Lumos Diagnostics (ASX:LDX) announced a new three-year contract manufacturing agreement for the innovative Micro-Pak Mold Analyser system.
Health
Pro Medicus secures $23M University of Maryland contract
Pro Medicus (ASX:PME) secured a five-year, $23 million contract with the University of Maryland Medical System.
Technology
Applied Digital posts triple-digit revenue growth as AI infrastructure demand scales
Applied Digital (NASDAQ:APLD), a designer and operator of next-generation digital infrastructure for high-performance computing (HPC) and artificial intelligence, reported a 139% year-over-year revenue increase for its third fiscal quarter of 2026 on April 8, 2026.
Retail
Chewy accelerates healthcare strategy with acquisition of Modern Animal
Chewy (NYSE:CHWY) announced on April 8, 2026, that it has entered into a definitive agreement to acquire Modern Animal, a technology-driven veterinary platform.
Adagio Medical secures FDA nod to expand clinical trial for next-gen VT ablation system
Adagio Medical Holdings (NASDAQ:ADGM) announced on April 8, 2026, that the U.S. Food and Drug Administration (FDA) granted Investigational Device Exemption (IDE) approval to expand its FULCRUM-VT clinical trial.
Mining
Osisko Gold Royalties reports record Q1 2026 revenue
Osisko Gold Royalties(NYSE:OR) reported record-breaking preliminary financial results for the first quarter of 2026 on April 8, bolstered by strong production across its core royalty portfolio and high precious metal prices.